Literature DB >> 31671023

17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study.

Lindsay J Collin1, Sinna P Ulrichsen2, Thomas P Ahern3, Michael Goodman1, Lauren E McCullough1, Lance A Waller4, Kristina Bang Christensen5, Per Damkier6,7, Stephen Hamilton-Dutoit5, Kristina L Lauridsen5, Rami Yacoub1, Peer M Christiansen8, Bent Ejlertsen9,10, Henrik Toft Sørensen2,11, Deirdre P Cronin-Fenton2, Timothy L Lash1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31671023      PMCID： PMC7033004          DOI： 10.1080/0284186X.2019.1684560

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  24 in total

1.  Inverse probability weighting.

Authors:  Mohammad Ali Mansournia; Douglas G Altman
Journal:  BMJ       Date:  2016-01-15

2.  Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells.

Authors:  Chen-Yan Zhang; Wei-Qi Wang; Jiong Chen; Sheng-Xiang Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-23       Impact factor: 4.292

3.  Abnormal expression of 17beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence.

Authors:  C Gunnarsson; B M Olsson; O Stål
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

4.  17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.

Authors:  Juliette A Aka; Mausumi Mazumdar; Chang-Qing Chen; Donald Poirier; Sheng-Xiang Lin
Journal:  Mol Endocrinol       Date:  2010-02-19

5.  20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Authors:  Hongchao Pan; Richard Gray; Jeremy Braybrooke; Christina Davies; Carolyn Taylor; Paul McGale; Richard Peto; Kathleen I Pritchard; Jonas Bergh; Mitch Dowsett; Daniel F Hayes
Journal:  N Engl J Med       Date:  2017-11-09       Impact factor: 91.245

6.  The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.

Authors:  Susanne Møller; Maj-Britt Jensen; Bent Ejlertsen; Karsten D Bjerre; Martin Larsen; Hanne B Hansen; Peer Christiansen; Henning T Mouridsen
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

7.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

8.  Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.

Authors:  Hope S Rugo; R Bryan Rumble; Erin Macrae; Debra L Barton; Hannah Klein Connolly; Maura N Dickler; Lesley Fallowfield; Barbara Fowble; James N Ingle; Mohammad Jahanzeb; Stephen R D Johnston; Larissa A Korde; James L Khatcheressian; Rita S Mehta; Hyman B Muss; Harold J Burstein
Journal:  J Clin Oncol       Date:  2016-05-23       Impact factor: 44.544

9.  17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.

Authors:  C Gunnarsson; E Hellqvist; O Stål
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

Review 10.  Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.

Authors:  Erik Hilborn; Olle Stål; Agneta Jansson
Journal:  Oncotarget       Date:  2017-05-02
View more
  2 in total

1.  The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis.

Authors:  Yunmeng Nie; Fang Huang; Lihua Lou; Junbin Yan
Journal:  Med Sci Monit       Date:  2022-02-20

2.  Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.

Authors:  Beata Filip-Psurska; Mateusz Psurski; Artur Anisiewicz; Patrycja Libako; Ewa Zbrojewicz; Magdalena Maciejewska; Michał Chodyński; Andrzej Kutner; Joanna Wietrzyk
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.